Navigation Links
Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
Date:6/27/2012

HAYWARD, Calif., June 27, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced results from the Phase 2b PEARL-SC clinical study in patients with systemic lupus erythematosus.The purpose of the PEARL-SC study was to identify an effective and safe dose for future phase 3 clinical studies and explore key inclusion criteria and clinical endpoints in an effort to maximize differentiation of blisibimod from currently available therapies.  The 200mg weekly subcutaneous dose of blisibimod demonstrated a strong trend in improved clinical response as early as week 16 (p= 0.14), at the primary endpoint (p=0.15) and throughout week 44 including a statistically significant improvement at week 20 versus placebo (p=0.02).

In a predefined phase 3 target population of severely ill, seropositive lupus patients, defined as SELENA-SLEDAI ≥10 and receiving background corticosteroid medication, a more pronounced effect was seen in the 200mg weekly dose group demonstrating a 13.8% treatment difference compared to placebo at 24 weeks.  In this subgroup, planned for phase 3 studies, separation of clinical response occurred as early as week 8 and was also sustained through week 44.  Results from the 200mg weekly group are presented in Table 1.

"The extensive data in the target severe population from our Phase 2 clinical program supports the initiation of a much smaller yet differentiated Phase 3 registration plan with the selected dose of blisibimod in patients with severe systemic lupus erythematosus.  We have prospectively demonstrated for the first time the possibility for a subcutaneously administered BAFF inhibitor to be used in the treatment of a severe lupus population.  The subgroup of severe pat
'/>"/>

SOURCE Anthera Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
2. Anthera Announces First Quarter 2012 Financial Report and Conference Call
3. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
4. Neuralstem Updates ALS Stem Cell Trial Progress
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
7. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
8. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
9. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
10. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Telbec/ - Russell Williams , President of ... the 2015-2016 Quebec Budget, noting the fiscal discipline and ... industry. However, the association is concerned about the decline ... government,s intent to strive for a balanced budget this ... Quebec,s economic development is encouraging," said ...
(Date:3/27/2015)... 2015  Victoria Vein & Surgery Clinic is the only ... laser in Victoria, Texas . The clinic ... advanced laser treatments for a variety of medical and cosmetic ... provide more services for their patients. Since adding laser tattoo ... Victoria residents get rid of their unwanted ink. ...
(Date:3/27/2015)... , March 27, 2015 A new report from ... America – Chile , ... are top targets for IVD firms.  The healthcare research firm ... into IVD strategies for the Latin American continent with a ... globally distributed supply operations. However, the country,s regional economic clout ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... AMSTERDAM , May 11 ... volcanic cloud, leading events organiser UBM International Media and sister ... attendance of 14,435 at its 2010 Japanese Pharma events cluster, ... Big Sight Exhibition Center. Representing an increase of 3.8% over ...
... , Event to Highlight Progress in Research, Advocacy and New Treatments , ... WASHINGTON , May 11 The National Organization for ... that have brought innovative new treatments to market for rare diseases at the 2010 NORD ... on Tuesday, May 18 . , , ...
Cached Medicine Technology:UBM Japan Pharma Events Grow Despite Air Travel Disruptions 2UBM Japan Pharma Events Grow Despite Air Travel Disruptions 3UBM Japan Pharma Events Grow Despite Air Travel Disruptions 4NORD to Honor Rare Disease Innovators 2NORD to Honor Rare Disease Innovators 3NORD to Honor Rare Disease Innovators 4
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 How ... is a growing field in orthopaedic medicine. While diagnostic ... tear to confirm the pain etiology, research presented today ... AOSSM ) Specialty Day suggests that pain relief from ... arthroscopic hip surgery. , “Our study looked to ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Early surgery ... with Type V AC joint injuries, according to new ... today at the American Orthopaedic Society for Sports Medicine’s ... to duty faster when surgery was not performed. , ... 7 receiving surgical treatment and 17 receiving non-surgical therapy. ...
(Date:3/28/2015)... 28, 2015 Andrew Hawley of Vintage Rock ... psychedelic concert posters. The Who and the Doors played together ... 2, 1968. According to Hawley, “The Who toured the United ... and college campuses. Perhaps the most famous Who poster was ... and the Doors on August 2, 1968 at the Singer ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 ... new method of sustainable health. After 18 years of ... life, including professional UFC contenders, Dr. Jon Petrick is ... summer. , Just some of the immediate benefits of ... and vitality, increased levels of strength of the immune ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2
... Jewish Health has received a grant for $950,308 from ... San Luis Valley with educational materials for patients and ... the most common chronic illness in children and adults, ... The San Luis Valley has one of the highest ...
... his State of the State announcement of a tenfold ... Kasich joined medical researchers from across the state on ... the faster network speeds will help enhance innovation. ... Medical Center, Case Western Reserve University School of Medicine, ...
... Mann HealthDay Reporter , MONDAY, Feb. 27 (HealthDay ... much needed rest at night, but using them routinely might ... develop certain types of cancer, research suggests. A new ... times more likely to die than people who don,t take ...
... is studying the differences between the social impairments found ... for people with both disorders. Autism spectrum disorder ... but they share similarities in social dysfunction. For many ... young people with ASD were thought to have a ...
... heart disease may not be able to compensate for their ... to Penn State researchers, making snow shoveling and other activities ... why cold air is such a trigger for coronary events," ... of the Heart and Vascular Institute, Penn State College of ...
... EAST LANSING, Mich. Often faced with overwhelming anxiety, patients ... and new research recommends nurses play a key role in ... patients. A diagnosis of lung cancer the leading ... with it high levels of stress and raises existential issues ...
Cached Medicine News:Health News:National Jewish Health receives grant to improve care of asthma patients in the San Luis Valley 2Health News:National Jewish Health receives grant to improve care of asthma patients in the San Luis Valley 3Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 2Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 3Health News:Sleeping Pills Linked to Raised Risk of Death, Cancer: Study 2Health News:Sleeping Pills Linked to Raised Risk of Death, Cancer: Study 3Health News:Study compares traits of autism, schizophrenia 2Health News:Cold air chills heart's oxygen supply 2Health News:Nurses key in helping new cancer patients overcome fears 2
... S600 ranks among Zebra's most popular printers. ... count on consistent, reliable performance. The S600 ... and Zebra Printer Management for real-time connectivity ... full-sized roll of media within the printer, ...
... High Performance line, Zebra's 110XiIIIPlus is a true ... printer is the one to call on for ... with either 4.09 inch (104 mm) or 3.2 ... best meets your needs, either 200, 300, or ...
... printing, the H 2824-Z direct thermal barcode ... improved patient safety and privacy. Generating clear ... variety of wristband types, the H 2824-Z ... on demand. It can also print bar ...
... The industrys first 600 dpi printer ... large amounts of bar code, text ... space. This printer is ideal for ... electronic components, telecommunication assemblies, computer peripherals, ...
Medicine Products: